HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teoh, K. H. Articles by Rosenfeld, J. M. Search for Related Content PubMed PubMed Citation Articles by Teoh, K. H. Articles by Rosenfeld, J. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 332-341, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass

KH Teoh, GT Christakis, RD Weisel, PY Wong, AV Mee, J Ivanov, MM Madonik, DS Levitt, PA Reilly and JM Rosenfeld
Division of Cardiovascular Surgery, Toronto General Hospital, Ontario, Canada.

Cardiopulmonary bypass activates and depletes platelets, which may contribute to postoperative bleeding. In addition, activated platelets may be deposited in the coronary vasculature after ischemia and cardioplegia, which may delay recovery of cardiac function and metabolism and may contribute to early bypass graft occlusion. The antiplatelet agent dipyridamole reduces platelet activation and depletion and may decrease postoperative bleeding and transfusion requirements. A prospective randomized trial was conducted in 58 patients undergoing elective coronary bypass operations to compare the effects of oral (19 patients) and intravenous (21 patients) dipyridamole to the results obtained in a control group (18 patients) who received no dipyridamole. Preoperative oral administration of dipyridamole resulted in lower plasma drug concentrations in the early postoperative period than perioperative intravenous administration (p = 0.0001 by analysis of variance). Postoperative arterial platelet counts were highest in the patients receiving intravenous dipyridamole, intermediate in those receiving oral dipyridamole, and lowest in the control group (p = 0.03 by analysis of variance). Postoperative blood loss and blood product transfusions were significantly reduced with both oral and intravenous dipyridamole (p = 0.04 by analysis of variance). Dipyridamole preserved platelets and reduced postoperative bleeding. Intravenous dipyridamole resulted in higher platelet counts than oral dipyridamole and may be required to reduce postoperative bleeding in high-risk patients.

This article has been cited by other articles:

				The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]

				S. Tabata, S. Yamaguchi, H. Nagamine, S. Tomita, S. Arai, H. Takemura, and G. Watanabe Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 289 - 293. [Abstract] [Full Text] [PDF]

				E. J Fransen, D. S de Jong, W. T. Hermens, and J. G Maessen Is postoperative blood loss, loss of blood? A pilot study in cardiac surgical patients Perfusion, July 1, 2001; 16(4): 301 - 308. [Abstract] [PDF]

				M. Chello, P. Mastroroberto, E. Malta, F. Cirillo, and V. Celi Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery Ann. Thorac. Surg., May 1, 1999; 67(5): 1277 - 1282. [Abstract] [Full Text] [PDF]

				A. Weerasinghe and K. M. Taylor The platelet in cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152. [Abstract] [Full Text] [PDF]

				K. Mellgren, G. Mellgren, S. Lundin, A. Wennmalm, and H. Wadenvik Effect of Nitric Oxide Gas on Platelets During Open Heart Operations Ann. Thorac. Surg., May 1, 1998; 65(5): 1335 - 1341. [Abstract] [Full Text] [PDF]

				G. Cohen, J. Ivanov, R. D. Weisel, V. Rao, M. K. Mohabeer, and D. A. G. Mickle Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Ann. Thorac. Surg., March 1, 1998; 65(3): 674 - 683. [Abstract] [Full Text] [PDF]

				O. Shigeta, H. Kojima, T. Jikuya, Y. Terada, N. Atsumi, Y. Sakakibara, T. Nagasawa, and T. Mitsui Aprotinin Inhibits Plasmin-Induced Platelet Activation During Cardiopulmonary Bypass Circulation, July 15, 1997; 96(2): 569 - 574. [Abstract] [Full Text]

				P. Hornick and A. George Blood contact activation: pathophysiological effects and therapeutic approaches Perfusion, January 1, 1996; 11(1): 3 - 19. [PDF]

				R. G. H. Speekenbrink, A. B. A. Vonk, C. R. H. Wildevuur, and L. Eijsman Hemostatic Efficacy of Dipyridamole, Tranexamic Acid, and Aprotinin in Coronary Bypass Grafting Ann. Thorac. Surg., February 1, 1995; 59(2): 438 - 442. [Abstract] [Full Text]

				A. Bernabei, N. Gikakis, M. A. Kowalska, S. Niewiarowski, and L. H. Edmunds Jr Iloprost and Echistatin Protect Platelets During Simulated Extracorporeal Circulation Ann. Thorac. Surg., January 1, 1995; 59(1): 149 - 153. [Abstract] [Full Text]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				K. M Taylor The scope of the problem Perfusion, May 1, 1993; 8(1_suppl): 1 - 5. [Abstract] [PDF]

				R. D Weisel Agents that modify haemostasis after cardiopulmonary bypass Perfusion, May 1, 1993; 8(1_suppl): 6 - 12. [Abstract] [PDF]

				D. Pearson Bleeding following open-heart surgery Perfusion, January 1, 1990; 5(1_suppl): 53 - 56. [PDF]

				D. Royston Aprotinin in open-heart surgery: background and results in patients having aortocoronary bypass grafts Perfusion, January 1, 1990; 5(1_suppl): 63 - 72. [PDF]